现货大促销,价格低至8折起,量大更优惠,详细咨询客服
全部分类
全部分类
  • Cyclobenzaprine-d3 (hydrochloride) (CRM)
Cyclobenzaprine-d3 (hydrochloride) (CRM)的可视化放大

Cyclobenzaprine-d3 (hydrochloride) (CRM)

A Certified Reference Material

原价
¥2387-2387
价格
1910-1910
Cyclobenzaprine-d3 (hydrochloride) (CRM)的二维码

所有产品仅用于科学研究,我们不为任何个人用途提供产品和服务

询价有惊喜,量大更优惠 点击这里给我发消息

  • 库存: 现货
可选包装 >>>
首页
  • 货号: ajcx24578
  • CAS: 1184983-42-3
  • 别名: 盐酸环苯扎林-D3,MK130-d3 hydrochloride
  • 分子式: C20H18D3N?HCl
  • 分子量: 314.9
  • 纯度: >98%
  • 溶解度:
  • 储存: -20°C
  • 库存: 现货

Background

Cyclobenzaprine-d3 (hydrochloride) (CRM) contains three deuterium atoms at the terminal methyl group. It is intended for use as an internal standard for the quantification of cyclobenzaprine by GC- or LC-mass spectrometry. Cyclobenzaprine is a skeletal muscle relaxant that also has sedative properties.1,2,3 It has been shown to antagonize muscarinic receptors (Kis = 25, 60, and 6 nM for M1, M2, and M3, respectively), serotonin 5-HT2 receptors (Kis = 56 and 330 nM for 5-HT2C and 5-HT2B, respectively), and histamine H1 receptor (IC50 = 20 nM).4,5,6



1.Trivedi, R.K., and Patel, M.C.Development of a stability-indicating RP-UPLC method for rapid determination of metaxalone and its degradation products in solid oral dosage formSci.Pharm.80(2)353-366(2012) 2.Chou, R., Peterson, K., and Helfand, M.Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: A systematic reviewJ. Pain Symptom Manage.28(2)140-175(2004) 3.See, S., and Ginzburg, R.Choosing a skeletal muscle relaxantAmerican Family Physician78(3)365-370(2008) 4.Gregori-Puigjané, E., Setola, V., Hert, J., et al.Identifying mechanism-of-action targets for drugs and probesProc. Natl. Acad. Sci. USA109(28)11178-11183(2012) 5.Honda, M., Nishida, T., and Ono, H.Tricyclic analogs cyclobenzaprine, amitriptyline and cyproheptadine inhibit the spinal reflex transmission through 5-HT2 receptorsEuropean Journal of Pharmacology458(1-2)91-99(2003) 6.Lounkine, E., Keiser, M.J., Whitebread, S., et al.Large scale prediction and testing of drug activity on side-effect targetsNature486(7403)361-367(2012)

动态评分

0.0

没有评分数据
没有评价数据
一键回到顶部
展开 收缩
安捷凯在线客服